cervical cancer
Schistosomiasis Alters Genes Related to Cervical Cancer
Schistosoma haematobium infection can trigger cancer-related gene activity in the cervical lining, with changes ...
MAY 2, 2025
Overall Survival Benefit Supports New Standard in High-Risk, Locally Advanced Cervical Cancer
In patients with high risk, locally advanced cervical cancer, previously reported data demonstrated an advantage ...
OCTOBER 10, 2024
FDA Fully Approves Tivdak for Recurrent or Metastatic Cervical Cancer
The FDA has granted traditional approval to tisotumab vedotin-tftv (Tivdak, Seagen [now part of Pfizer]) for ...
MAY 1, 2024
Keytruda With Chemoradiotherapy Approved for FIGO 2014 Stage III-IVA Cervical Cancer
The FDA approved pembrolizumab (Keytruda, Merck) with chemoradiotherapy (CRT) for patients with FIGO 2014 stage III ...
JANUARY 17, 2024
In Recurrent/Metastatic Cervical Cancer, Tisotumab Vedotin Improves Survival
In patients with recurrent or metastatic cervical cancer, treatment with the antibody–drug conjugate ...
NOVEMBER 6, 2023
Gynecologic Cancer Misinformation Prevalent on TikTok
Gynecologic cancer–related content on the TikTok social media platform is of poor educational quality, and ...
OCTOBER 6, 2023
Trastuzumab Deruxtecan Demonstrates Benefit Across an Array of HER2-Expressing Tumors
The antibody–drug conjugate trastuzumab deruxtecan (T-DXd) (Enhertu, Daiichi Sankyo/AstraZeneca) is emerging ...
JULY 7, 2023
Study Highlights Value of Patient Navigation for Rural Cancer Screening
In rural parts of the United States, providing patient navigation services and a tailored educational video ...
MAY 19, 2023
Pembrolizumab Plus Chemo Called New Advanced Cervical Cancer Standard
Adding the checkpoint inhibitor pembrolizumab to conventional chemotherapy in women with persistent, recurrent or ...
FEBRUARY 8, 2022
Trial Discourages More Chemotherapy for Locally Advanced Cervical Cancer
In women with locally advanced cervical cancer, additional chemotherapy after standard chemoradiation does not ...
NOVEMBER 12, 2021
FDA Approves Tivdak for Recurrent or Metastatic Cervical Cancer
The FDA granted accelerated approval to tisotumab vedotin-tftv (Tivdak, Seagen/Genmab), a tissue ...
SEPTEMBER 24, 2021
Single HPV Vaccine Dose May Be Effective Against Cervical Cancer
A single dose of the HPV vaccine may be as effective as multiple doses for preventing preinvasive cervical disease. ...
MARCH 4, 2020
